Lledo, Merry Ann .

HRN: 28-74-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2026
04/28/2026
IV
500 Mg
Q8 X 4 Doses
SP 1LTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: